3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
29
Phase 1
26
Phase 1/2
16
Phase 3
5
Phase EARLY_PHASE1
2
Phase NA
1
Phase 2/3
1
Status
Completed
4
Recruiting
3
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Breast Neoplasms
13
Neoplasms
10
Carcinoma, Non-Small-Cell Lung
10
Lung Neoplasms
9
Recurrence
6
Prostatic Neoplasms
6
Neoplasm Metastasis
6
Head and Neck Neoplasms
6
Carcinoma, Hepatocellular
6
Stomach Neoplasms
5
Pancreatic Neoplasms
5
Colorectal Neoplasms
5
Carcinoma, Squamous Cell
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Multiple Myeloma
4
Melanoma
4
Liver Neoplasms
4
Ovarian Neoplasms
3
Myelodysplastic Syndromes
3
Lymphoma, Non-Hodgkin
3
Lymphoma, Large B-Cell, Diffuse
3
Hematologic Neoplasms
3
Fatigue
3
Esophageal Neoplasms
3
Endometrial Neoplasms
3
Depression
3
Urinary Bladder Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma
2
Rectal Neoplasms
2
Interventions
valrubicin
1
Oncolytic Virotherapy
1
Mitomycin
1
Interferons
1
Gemcitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2/3
×
Terminated
×
Carcinoma, Transitional Cell
×
Clear all
NCT01438112
2021-04-14
BOND
CG Oncology, Inc.
Phase 2/3
Terminated
22 enrolled